Celldex Therapeutics CLDX SEC Filings

NASDAQ CLDX
$39.30 -0.07 (-0.18%)
As of: Sep 4, 2026 · 11:47 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Celldex Therapeutics, Inc. (CLDX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index